Sponsor Pipeline

Nagoya City University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06535893 Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast… Breast Cancer Recruiting
NCT07292207 Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2… ctDNA Monitoring Not Yet Recruiting
Phase 1/2
NCT07164976 Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer Breast Cancer Recruiting
Not specified
NCT06542484 The Real-world Treatment Satisfaction by Gefapixiant in RCC Chronic Cough Recruiting
NCT06663787 Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer… Breast Cancer, Metastatic Active, Not Recruiting
Disease Areas
Breast Cancer (4)
Get alerts when Nagoya City University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free